These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10987352)

  • 21. Changes in midwall systolic performance and cardiac hypertrophy reduction in hypertensive patients.
    Muiesan ML; Salvetti M; Monteduro C; Rizzoni D; Corbellini C; Castellano M; Porteri E; Agabiti-Rosei E
    J Hypertens; 2000 Nov; 18(11):1651-6. PubMed ID: 11081779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
    Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy.
    Mayet J; Ariff B; Wasan B; Chapman N; Shahi M; Poulter NR; Sever PS; Foale RA; Thom SA
    Hypertension; 2000 Nov; 36(5):755-9. PubMed ID: 11082139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of verapamil on left ventricular mass and diastolic function in hypertensive patients].
    Sau F; Seguro C; Alvau MD; Pargentino E; Cherchi A
    Cardiologia; 1993 Nov; 38(11):727-32. PubMed ID: 8004645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of enalapril on left ventricular mass and diastolic function in essential hypertension: special reference to duration of hypertension.
    Oki T; Fukuda N; Iuchi A; Tabata T; Sasaki M; Kawahara K; Ishimoto T; Tominaga T; Okushi H; Fujimoto T; Ito S
    J Card Fail; 1995 Dec; 1(5):365-70. PubMed ID: 12836711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive treatment in hypertensive patients with normal left ventricular mass is associated with left ventricular remodeling and improved diastolic function.
    Schulman DS; Flores AR; Tugoen J; Dianzumba S; Reichek N
    Am J Cardiol; 1996 Jul; 78(1):56-60. PubMed ID: 8712119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy.
    Fagard RH; Staessen JA; Thijs L
    J Hypertens; 1997 Dec; 15(12 Pt 1):1493-502. PubMed ID: 9431857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
    Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].
    Amici E; Patruno N; Natale E; Marsocci A; Gambelli G
    Cardiologia; 1993 Sep; 38(9):585-91. PubMed ID: 8287388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect: evidence from the sample study.
    Omboni S; Fogari R; Palatini P; Rappelli A; Mancia G
    Hypertension; 1998 Sep; 32(3):424-9. PubMed ID: 9740606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Regression of left ventricular hypertrophy and improvement of its diastolic function in patients with arterial hypertension under influence of antihypertensive therapy].
    Borzova NV; Gorbachenkov AA
    Kardiologiia; 2008; 48(6):44-50. PubMed ID: 18729836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
    Devereux RB; Palmieri V; Liu JE; Wachtell K; Bella JN; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Dahlöf B
    J Hypertens; 2002 Jul; 20(7):1445-50. PubMed ID: 12131543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Gottdiener JS; Reda DJ; Massie BM; Materson BJ; Williams DW; Anderson RJ
    Circulation; 1997 Apr; 95(8):2007-14. PubMed ID: 9133508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril.
    Oren S; Grossman E; Frohlich ED
    Am J Cardiol; 1996 Jan; 77(1):93-6. PubMed ID: 8540468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of regression of left ventricular hypertrophy from systemic hypertension on systolic function assessed by midwall shortening (HOT echocardiographic study).
    Zabalgoitia M; Rahman SN; Haley WE; Yarows S; Krause L; Anderson LC; Oraby MA; Amarena J
    Am J Cardiol; 2001 Sep; 88(5):521-5. PubMed ID: 11524061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects on cardiac arrhythmias of antihypertensive therapy causing regression of left ventricular hypertrophy.
    Mayet J; Chapman N; Shahi M; Poulter NR; Cunningham DA; Dave S; Kooner J; Sever PS; Foale RA; Thom SA
    Am J Hypertens; 1997 Jun; 10(6):611-8. PubMed ID: 9194506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension.
    Parati G; Omboni S; Rizzoni D; Agabiti-Rosei E; Mancia G
    J Hypertens; 1998 Nov; 16(11):1685-91. PubMed ID: 9856370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension.
    Fogari R; Zoppi A; Mugellini A; Tettamanti F; Lusardi P; Corradi L
    Eur Heart J; 1995 Aug; 16(8):1120-5. PubMed ID: 8665975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of systolic and diastolic properties of hypertensive heart failure using speckle-tracking echocardiography with high volume rates.
    Minatoguchi S; Kawasaki M; Tanaka R; Yoshizane T; Ono K; Saeki M; Nagaya M; Sato H; Nishigaki K; Noda T; Zile MR; Minatoguchi S
    Heart Vessels; 2017 Oct; 32(10):1202-1213. PubMed ID: 28638961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.